Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation

Institut de Cancérologie de la Loire2 sites in 1 country9 target enrollmentApril 2014

ConditionsProstate Cancer

Overview

Phase: N/A
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: Institut de Cancérologie de la Loire
Enrollment: 9
Locations: 2
Primary Endpoint: Number of patients who refused to participate
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to build and assess the feasibility of a therapeutic education program, constructed in collaboration with the urologists of the University Hospital of Saint Etienne. The aim of this therapeutic education program is to delay the onset or to reduce the amplitude of the development of insulin resistance and side effects of androgen deprivation therapy in patients treated with androgen deprivation in the context of an evolutive prostate cancer.

Registry

clinicaltrials.gov

Start Date

April 2014

End Date

November 2014

Last Updated

10 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Male

Investigators

Sponsor

Institut de Cancérologie de la Loire

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients supported in consultation Urology at the University Hospital North Saint Etienne.
•Aged over 18 years
•Having an evolutive prostate cancer
•Patient treated with LHRH agonist for at least 6 months - Affiliated with the national health insurance system
•And having completed the worksheet informed consent to participate in the program.

Exclusion Criteria

•Refusal of participation, protected or under guardianship patients.
•Patients unable to understand the study or unable to follow the educational sessions.
•Patient (s) with documented cognitive or psychiatric history.
•Geographical remotness (more than 100 Kms.)